PubMed Health⌕ Search

Biomedical subjects

A Georoceanu

Publications and source records attributed to A Georoceanu.

8 recordsLinked to original sources

Risk of asymptomatic and symptomatic gallstones in moderately obese women: a longitudinal follow-up study.

Obesity is a rather documented risk factor for the formation of gallstones (GS) in women. The magnitude of the increased risk and the rates of GS occurrence, however, have not been well quantified, except for two studies on the risk of symptomatic stones in obese women. We analyzed the incidence of GS in 157 moderately obese women (body mass index, 31.4 +/- 3.6 kg/ m2) followed up prospectively by ultrasound for 2-6 yr (mean 3.95 yr). Women with morbid obesity (body mass index > 40 kg/m2) were excluded from the study, as well as patients having diseases with lithogenic risk. All the enrolled women had normal cholecystosonogram results at the beginning of the study. Age, family history of GS or obesity, parity, age of obesity onset, hyperlipoproteinemia type, plasma cholesterol (total, HDL, LDL), and triglycerides were assessed. The Student's t, the Mann-Whitney rank sum and the Fisher's exact tests were used, as well as the multiple logistic regression for the multivariate analysis. During the survey, 16 of 157 women (10.2%) developed GS. GS were asymptomatic in 11 persons (68.8%). The cumulative incidence of both asymptomatic and symptomatic GS was 2.6 cases/100 obese women.year. During the follow-up, most of the detected GS were asymptomatic, and this explains the higher GS incidence rate found compared with that previously calculated for symptomatic GS. The following risk factors were associated with GS formation: age (p = 0.002), family history of GS (p = 0.011), early obesity onset (p = 0.003), and hyperlipoproteinemia type IV (p = 0.011). A high risk class might be thus identified among obese women, offering a more realistic approach for the primary prophylaxis of GS.

Adult↗

Beta adrenergic regulation of the hydrochloric acid secretion.

Propranolol induces basal achlorhydria in 30.7% of the patients, decreases significantly the HCl secretion in 42.3%, does not change it in 25% and increases it in 1.9%. After histamine stimulation (Kay test) propranolol decreases HCl in 57% and increases it in 43% of the cases. Propranolol induces a significant decrease of carbon anhydrase in the gastric mucosa. Serum gastrin is not significantly decreased after propranolol treatment. Isoprenaline increases the HCl secretion in all the patients investigated. Propranolol suppresses the effect of isoprenaline in 28.6% of the cases, decreases it in 33%, does not change it in 19% and increases it in 19%. The action of isoprenaline is not influenced by atropine, so the mechanism of action of the beta agonist is non-cholinergic. The gastric juice volume is not changed significantly by the blockage or stimulation of beta receptors. The beta adrenergic nervous system stimulates HCl secretion.

Adult↗

Some aspects of cellular and humoral immunity in bronchial asthma and allergic rhinitis.

Blood lymphocyte subpopulations were investigated in 50 patients with allergic diseases (38 with allergic rhinitis and 12 with allergic bronchial asthma). The total T lymphocyte (Tt) count (E rosette test), the active T lymphocyte (Ta) count (active E rosette test) and the B lymphocyte count (EAC rosette test) were determined and the results were correlated with: 1) lymphocyte sensitization in vitro to different allergens and to PPD; 2) circulating immune complexes; 3) serum histaminopexic capacity. In allergic rhinites a decrease of Tt and B lymphocytes and an increase of Ta lymphocytes was observed. In allergic bronchial asthma the Tt lymphocyte were found reduced. Lymphocyte reactivity to PPD in vitro was present in 100% of the cases and in vitro lymphocyte sensitivity to several allergens was observed in most of the cases. The histaminopexic capacity was absent or low in 75% of the patients with allergic rhinitis and in 66.6% of the patients with allergic bronchial asthma. The involvement of cellular mediated immunity in allergic diseases is discussed.

Adult↗

Test of leukocyte migration inhibition. 1. Value of the test in the diagnosis of certain immune diseases.

The test of leukocyte migration inhibition (LMI) being a specific and sensitive method for the detection of cell-mediated immunity, its ever increasing use in the clinic necessitates a more accurate estimation of its actual value. The technique used in this study is that of leukocyte migration in capillary tubes according to Soborg and Bendixen. The test was performed in three groups of patients: A--with drug intoxication; B--with chronic post viral hepatitis and C--with alcoholic liver disease. The results obtained showed that in the patients with drug allergy the LMI test using the incriminated drugs as antigens was positive in 83% of the cases, in the patients with chronic post viral hepatitis the cellular migration inhibition to the HBsAg was observed in 35% of the cases and in alcoholic liver disease lymphocyte sensitization to ethanol was present in 28.7% of the cases. It is concluded that in drug allergy the LMI test is useful and has diagnostic value being preferable to other in vitro determinations and even, in certain cases, to the skin tests. In chronic liver diseases the value of the test is limited to investigation purposes as it can reveal the degree of involvement of cell-mediated immunity in the pathogenesis of disease.

Drug Hypersensitivity↗